JP2015509543A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509543A5 JP2015509543A5 JP2014561149A JP2014561149A JP2015509543A5 JP 2015509543 A5 JP2015509543 A5 JP 2015509543A5 JP 2014561149 A JP2014561149 A JP 2014561149A JP 2014561149 A JP2014561149 A JP 2014561149A JP 2015509543 A5 JP2015509543 A5 JP 2015509543A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- amino
- carbonyl
- isoquinoline
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 51
- 125000003118 aryl group Chemical group 0.000 claims description 47
- -1 amino, substituted amino Chemical group 0.000 claims description 40
- 229910052739 hydrogen Inorganic materials 0.000 claims description 29
- 239000001257 hydrogen Substances 0.000 claims description 29
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- 125000001072 heteroaryl group Chemical group 0.000 claims description 27
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 24
- 125000001475 halogen functional group Chemical group 0.000 claims description 23
- 125000000623 heterocyclic group Chemical group 0.000 claims description 20
- 102100037248 Prolyl hydroxylase EGLN2 Human genes 0.000 claims description 15
- 101710170760 Prolyl hydroxylase EGLN2 Proteins 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 150000002431 hydrogen Chemical class 0.000 claims description 13
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 13
- 102100037249 Egl nine homolog 1 Human genes 0.000 claims description 11
- 101710111663 Egl nine homolog 1 Proteins 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 125000004442 acylamino group Chemical group 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 9
- 239000000651 prodrug Substances 0.000 claims description 9
- 229940002612 prodrug Drugs 0.000 claims description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 150000003857 carboxamides Chemical group 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 125000005110 aryl thio group Chemical group 0.000 claims description 6
- 102100037247 Prolyl hydroxylase EGLN3 Human genes 0.000 claims description 5
- 101710170720 Prolyl hydroxylase EGLN3 Proteins 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims description 5
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000006598 aminocarbonylamino group Chemical group 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 4
- 125000005366 cycloalkylthio group Chemical group 0.000 claims description 4
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 claims description 4
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- PNTSTXDGTUPCTD-GOSISDBHSA-N (2r)-2-acetamido-4-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC[C@@H](NC(=O)C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 PNTSTXDGTUPCTD-GOSISDBHSA-N 0.000 claims description 2
- UBEYTGBZRYCLOZ-GFCCVEGCSA-N (2r)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-methylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC[C@@H](C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 UBEYTGBZRYCLOZ-GFCCVEGCSA-N 0.000 claims description 2
- TTYWGSQNECYLRX-CHWSQXEVSA-N (2r,3r)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-methylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)N[C@H](C)[C@@H](C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 TTYWGSQNECYLRX-CHWSQXEVSA-N 0.000 claims description 2
- TTYWGSQNECYLRX-OLZOCXBDSA-N (2r,3s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-methylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)N[C@@H](C)[C@@H](C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 TTYWGSQNECYLRX-OLZOCXBDSA-N 0.000 claims description 2
- NNUUDWBQBNSVGR-HNNXBMFYSA-N (2s)-2-amino-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC[C@H](N)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 NNUUDWBQBNSVGR-HNNXBMFYSA-N 0.000 claims description 2
- LKKMGZPSABYQKE-HNNXBMFYSA-N (2s)-2-amino-3-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC[C@H](N)C(O)=O)=NC=C2C=C1OC1=CC=CC=C1 LKKMGZPSABYQKE-HNNXBMFYSA-N 0.000 claims description 2
- GUSZHYVWIFSYBU-SFHVURJKSA-N (2s)-2-benzyl-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C([C@@H](C(=O)O)CC=1C=CC=CC=1)NC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 GUSZHYVWIFSYBU-SFHVURJKSA-N 0.000 claims description 2
- GXDHDFVYIIBWGX-HNNXBMFYSA-N (2s)-2-hydroxy-3-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC[C@H](O)C(O)=O)=NC=C2C=C1OC1=CC=CC=C1 GXDHDFVYIIBWGX-HNNXBMFYSA-N 0.000 claims description 2
- HBPBZJAYBQVBDY-INIZCTEOSA-N (2s)-2-hydroxy-3-[[4-hydroxy-7-(4-methoxyphenoxy)isoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC(OC)=CC=C1OC1=CC=C(C(O)=C(N=C2)C(=O)NC[C@H](O)C(O)=O)C2=C1 HBPBZJAYBQVBDY-INIZCTEOSA-N 0.000 claims description 2
- XNRNJKKKWOCNLH-HNNXBMFYSA-N (2s)-2-hydroxy-3-[[4-hydroxy-7-(phenylcarbamoylamino)isoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC[C@H](O)C(O)=O)=NC=C2C=C1NC(=O)NC1=CC=CC=C1 XNRNJKKKWOCNLH-HNNXBMFYSA-N 0.000 claims description 2
- IGBKLAZQWUSTAU-INIZCTEOSA-N (2s)-2-hydroxy-4-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC[C@H](O)C(O)=O)=NC=C2C=C1OC1=CC=CC=C1 IGBKLAZQWUSTAU-INIZCTEOSA-N 0.000 claims description 2
- GAXREOLLPRQLNE-QHCPKHFHSA-N (2s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)NC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 GAXREOLLPRQLNE-QHCPKHFHSA-N 0.000 claims description 2
- UOUOUOFRJQINNR-IBGZPJMESA-N (2s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC[C@H](NC(=O)OC(C)(C)C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 UOUOUOFRJQINNR-IBGZPJMESA-N 0.000 claims description 2
- OTQFWKODLCHMMB-INIZCTEOSA-N (2s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-hydroxypropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC[C@H](O)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 OTQFWKODLCHMMB-INIZCTEOSA-N 0.000 claims description 2
- UBEYTGBZRYCLOZ-LBPRGKRZSA-N (2s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-methylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC[C@H](C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 UBEYTGBZRYCLOZ-LBPRGKRZSA-N 0.000 claims description 2
- POGJKBIAZPPFAR-KRWDZBQOSA-N (2s)-4-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-hydroxybutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC[C@H](O)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 POGJKBIAZPPFAR-KRWDZBQOSA-N 0.000 claims description 2
- KFQULEWLVTWOGD-SFHVURJKSA-N (2s)-4-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-methoxybutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC[C@H](OC)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 KFQULEWLVTWOGD-SFHVURJKSA-N 0.000 claims description 2
- TTYWGSQNECYLRX-QWHCGFSZSA-N (2s,3r)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-methylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)N[C@H](C)[C@H](C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 TTYWGSQNECYLRX-QWHCGFSZSA-N 0.000 claims description 2
- DGJDZGFFYSIJTN-OAQYLSRUSA-N (3r)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-phenylpropanoic acid Chemical compound N([C@H](CC(=O)O)C=1C=CC=CC=1)C(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 DGJDZGFFYSIJTN-OAQYLSRUSA-N 0.000 claims description 2
- BXQLMPYZVJTCLU-HXUWFJFHSA-N (3r)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-pyridin-3-ylpropanoic acid Chemical compound N([C@H](CC(=O)O)C=1C=NC=CC=1)C(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 BXQLMPYZVJTCLU-HXUWFJFHSA-N 0.000 claims description 2
- LRKHSAOMPJQUKY-GOSISDBHSA-N (3r)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-4-phenylbutanoic acid Chemical compound C([C@H](CC(=O)O)NC(=O)C=1C(=C2C=CC(OC=3C=CC=CC=3)=CC2=C(C#N)N=1)O)C1=CC=CC=C1 LRKHSAOMPJQUKY-GOSISDBHSA-N 0.000 claims description 2
- WZJDYOWVFHSRTF-LJQANCHMSA-N (3r)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-5-phenylpentanoic acid Chemical compound C([C@H](CC(=O)O)NC(=O)C=1C(=C2C=CC(OC=3C=CC=CC=3)=CC2=C(C#N)N=1)O)CC1=CC=CC=C1 WZJDYOWVFHSRTF-LJQANCHMSA-N 0.000 claims description 2
- CTADYWAQKGRMMW-GFCCVEGCSA-N (3r)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)N[C@@H](CC(O)=O)C)=NC(C#N)=C2C=C1OC1=CC=CC=C1 CTADYWAQKGRMMW-GFCCVEGCSA-N 0.000 claims description 2
- XBMFFUGFOFOFEO-CYBMUJFWSA-N (3r)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)N[C@@H](CC(O)=O)CC)=NC(C#N)=C2C=C1OC1=CC=CC=C1 XBMFFUGFOFOFEO-CYBMUJFWSA-N 0.000 claims description 2
- LSGSPXIRMZTZQG-NRFANRHFSA-N (3s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-(2-fluorophenyl)propanoic acid Chemical compound N([C@@H](CC(=O)O)C=1C(=CC=CC=1)F)C(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 LSGSPXIRMZTZQG-NRFANRHFSA-N 0.000 claims description 2
- GIOAJCVNRUNIID-QFIPXVFZSA-N (3s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-(2-methylphenyl)propanoic acid Chemical compound CC1=CC=CC=C1[C@H](CC(O)=O)NC(=O)C1=NC(C#N)=C(C=C(OC=2C=CC=CC=2)C=C2)C2=C1O GIOAJCVNRUNIID-QFIPXVFZSA-N 0.000 claims description 2
- PBGXTOQPTZOOLG-QFIPXVFZSA-N (3s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-(4-cyanophenyl)propanoic acid Chemical compound N([C@@H](CC(=O)O)C=1C=CC(=CC=1)C#N)C(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 PBGXTOQPTZOOLG-QFIPXVFZSA-N 0.000 claims description 2
- DGJDZGFFYSIJTN-NRFANRHFSA-N (3s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-phenylpropanoic acid Chemical compound N([C@@H](CC(=O)O)C=1C=CC=CC=1)C(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 DGJDZGFFYSIJTN-NRFANRHFSA-N 0.000 claims description 2
- BXQLMPYZVJTCLU-FQEVSTJZSA-N (3s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-pyridin-3-ylpropanoic acid Chemical compound N([C@@H](CC(=O)O)C=1C=NC=CC=1)C(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 BXQLMPYZVJTCLU-FQEVSTJZSA-N 0.000 claims description 2
- LRKHSAOMPJQUKY-SFHVURJKSA-N (3s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-4-phenylbutanoic acid Chemical compound C([C@@H](CC(=O)O)NC(=O)C=1C(=C2C=CC(OC=3C=CC=CC=3)=CC2=C(C#N)N=1)O)C1=CC=CC=C1 LRKHSAOMPJQUKY-SFHVURJKSA-N 0.000 claims description 2
- CTADYWAQKGRMMW-LBPRGKRZSA-N (3s)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)N[C@H](CC(O)=O)C)=NC(C#N)=C2C=C1OC1=CC=CC=C1 CTADYWAQKGRMMW-LBPRGKRZSA-N 0.000 claims description 2
- WHDBRPBRHPLOCJ-UHFFFAOYSA-N 1-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]cyclobutane-1-carboxylic acid Chemical compound N=1C(C#N)=C2C=C(OC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCC1 WHDBRPBRHPLOCJ-UHFFFAOYSA-N 0.000 claims description 2
- JSYWJICQZNCWHF-UHFFFAOYSA-N 1-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]cyclopentane-1-carboxylic acid Chemical compound N=1C(C#N)=C2C=C(OC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCCC1 JSYWJICQZNCWHF-UHFFFAOYSA-N 0.000 claims description 2
- PDBNVENXRSQVKB-UHFFFAOYSA-N 1-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]cyclopropane-1-carboxylic acid Chemical compound N=1C(C#N)=C2C=C(OC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CC1 PDBNVENXRSQVKB-UHFFFAOYSA-N 0.000 claims description 2
- WZEVEULDNFXEFI-UHFFFAOYSA-N 1-[[(1-cyano-4-hydroxy-7-phenylsulfanylisoquinoline-3-carbonyl)amino]methyl]cyclobutane-1-carboxylic acid Chemical compound N=1C(C#N)=C2C=C(SC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCC1 WZEVEULDNFXEFI-UHFFFAOYSA-N 0.000 claims description 2
- NYIXYQZNDODKLM-UHFFFAOYSA-N 1-[[(1-cyano-4-hydroxy-7-pyridin-3-yloxyisoquinoline-3-carbonyl)amino]methyl]cyclobutane-1-carboxylic acid Chemical compound N=1C(C#N)=C2C=C(OC=3C=NC=CC=3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCC1 NYIXYQZNDODKLM-UHFFFAOYSA-N 0.000 claims description 2
- IVNASAIOJNMRBM-UHFFFAOYSA-N 1-[[(1-cyano-7-cyclohexyloxy-4-hydroxyisoquinoline-3-carbonyl)amino]methyl]cyclobutane-1-carboxylic acid Chemical compound N=1C(C#N)=C2C=C(OC3CCCCC3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCC1 IVNASAIOJNMRBM-UHFFFAOYSA-N 0.000 claims description 2
- RBUHJNXKWHHZST-UHFFFAOYSA-N 1-[[(1-cyano-7-cyclohexylsulfonyl-4-hydroxyisoquinoline-3-carbonyl)amino]methyl]cyclobutane-1-carboxylic acid Chemical compound N=1C(C#N)=C2C=C(S(=O)(=O)C3CCCCC3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCC1 RBUHJNXKWHHZST-UHFFFAOYSA-N 0.000 claims description 2
- FIVYBSPPKFZCNQ-UHFFFAOYSA-N 1-[[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]cyclobutane-1-carboxylic acid Chemical compound N=1C=C2C=C(OC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCC1 FIVYBSPPKFZCNQ-UHFFFAOYSA-N 0.000 claims description 2
- UFVTYNUQLCVARJ-UHFFFAOYSA-N 1-[[[1-cyano-7-(2,6-difluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]methyl]cyclobutane-1-carboxylic acid Chemical compound N=1C(C#N)=C2C=C(OC=3C(=CC=CC=3F)F)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCC1 UFVTYNUQLCVARJ-UHFFFAOYSA-N 0.000 claims description 2
- SLBHGGUKXNMPNZ-UHFFFAOYSA-N 2-[1-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]cyclohexyl]acetic acid Chemical compound N=1C(C#N)=C2C=C(OC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NC1(CC(=O)O)CCCCC1 SLBHGGUKXNMPNZ-UHFFFAOYSA-N 0.000 claims description 2
- IOROJGTUVPLIBU-UHFFFAOYSA-N 2-[1-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]cyclohexyl]acetic acid Chemical compound N=1C(C#N)=C2C=C(OC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NCC1(CC(=O)O)CCCCC1 IOROJGTUVPLIBU-UHFFFAOYSA-N 0.000 claims description 2
- XTXDQXMSFMWGFF-UHFFFAOYSA-N 2-[4-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]acetic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(CC(O)=O)NC(=O)C1=NC(C#N)=C(C=C(OC=2C=CC=CC=2)C=C2)C2=C1O XTXDQXMSFMWGFF-UHFFFAOYSA-N 0.000 claims description 2
- NXMYGAXOCIIGFJ-UHFFFAOYSA-N 2-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]-2-methylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(CC)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 NXMYGAXOCIIGFJ-UHFFFAOYSA-N 0.000 claims description 2
- PDDZFEWPTAIYGL-UHFFFAOYSA-N 2-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]-2-propylpentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(CCC)(CCC)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 PDDZFEWPTAIYGL-UHFFFAOYSA-N 0.000 claims description 2
- GFXZDIYEOSVKGA-UHFFFAOYSA-N 2-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(CC)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 GFXZDIYEOSVKGA-UHFFFAOYSA-N 0.000 claims description 2
- OUBAPWWJWLDPAF-UHFFFAOYSA-N 2-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(CCC)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 OUBAPWWJWLDPAF-UHFFFAOYSA-N 0.000 claims description 2
- ZFNDRNLFIFPWRJ-UHFFFAOYSA-N 2-cyclopropyl-3-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1CC1C(C(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC=C1C=C2OC1=CC=CC=C1 ZFNDRNLFIFPWRJ-UHFFFAOYSA-N 0.000 claims description 2
- LRSNPVQBAZNKKP-UHFFFAOYSA-N 3-(3-chlorophenyl)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C=1C=CC(Cl)=CC=1C(CC(=O)O)NC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 LRSNPVQBAZNKKP-UHFFFAOYSA-N 0.000 claims description 2
- JJGFFXQTLASLLF-UHFFFAOYSA-N 3-(4-chlorophenyl)-3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C=1C=C(Cl)C=CC=1C(CC(=O)O)NC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 JJGFFXQTLASLLF-UHFFFAOYSA-N 0.000 claims description 2
- QJQZBILZUKQCPA-UHFFFAOYSA-N 3-(4-chlorophenyl)-4-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C=1C=C(Cl)C=CC=1C(CC(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 QJQZBILZUKQCPA-UHFFFAOYSA-N 0.000 claims description 2
- TWYMKHJONDBQBE-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-2-oxido-7-phenoxyisoquinolin-2-ium-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=C2C(C#N)=[N+]([O-])C(C(=O)NCC(C)(C)C(O)=O)=C(O)C2=CC=C1OC1=CC=CC=C1 TWYMKHJONDBQBE-UHFFFAOYSA-N 0.000 claims description 2
- QDAUZTZISPORKG-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-6-phenoxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C=1C2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=CC=1OC1=CC=CC=C1 QDAUZTZISPORKG-UHFFFAOYSA-N 0.000 claims description 2
- QBSUFMQXFVGWJT-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-naphthalen-2-yloxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC=CC2=CC(OC3=CC4=C(C#N)N=C(C(=C4C=C3)O)C(=O)NCC(C)(C)C(O)=O)=CC=C21 QBSUFMQXFVGWJT-UHFFFAOYSA-N 0.000 claims description 2
- VYRFTLOPVJDRRR-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2,2-difluoropropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(F)(F)C(=O)O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 VYRFTLOPVJDRRR-UHFFFAOYSA-N 0.000 claims description 2
- WETDOHTXPFQGTC-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 WETDOHTXPFQGTC-UHFFFAOYSA-N 0.000 claims description 2
- RRUOOJXGLKPFSE-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-(2-fluorophenyl)propanoic acid Chemical compound C=1C=CC=C(F)C=1C(C(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 RRUOOJXGLKPFSE-UHFFFAOYSA-N 0.000 claims description 2
- KHSRHHLDXAQVLN-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-(4-fluorophenyl)propanoic acid Chemical compound C=1C=C(F)C=CC=1C(C(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 KHSRHHLDXAQVLN-UHFFFAOYSA-N 0.000 claims description 2
- PGIYKGVVSOBKQN-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-cyclopropylpropanoic acid Chemical compound C1CC1C(C(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 PGIYKGVVSOBKQN-UHFFFAOYSA-N 0.000 claims description 2
- OTQFWKODLCHMMB-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-hydroxypropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(O)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 OTQFWKODLCHMMB-UHFFFAOYSA-N 0.000 claims description 2
- LEMDOGKUYBBUNK-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-phenylpropanoic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 LEMDOGKUYBBUNK-UHFFFAOYSA-N 0.000 claims description 2
- SHDGQLVOAGJTGP-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-methylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC(C)(CC(O)=O)C)=NC(C#N)=C2C=C1OC1=CC=CC=C1 SHDGQLVOAGJTGP-UHFFFAOYSA-N 0.000 claims description 2
- DGJDZGFFYSIJTN-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-phenylpropanoic acid Chemical compound C=1C=CC=CC=1C(CC(=O)O)NC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 DGJDZGFFYSIJTN-UHFFFAOYSA-N 0.000 claims description 2
- BXQLMPYZVJTCLU-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-pyridin-3-ylpropanoic acid Chemical compound C=1C=CN=CC=1C(CC(=O)O)NC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1 BXQLMPYZVJTCLU-UHFFFAOYSA-N 0.000 claims description 2
- ATIUIKSZRIGNTQ-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-4-methylpentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC(CC(O)=O)C(C)C)=NC(C#N)=C2C=C1OC1=CC=CC=C1 ATIUIKSZRIGNTQ-UHFFFAOYSA-N 0.000 claims description 2
- ZCLCWANYQTWHIW-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-5-methylhexanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC(CC(O)=O)CC(C)C)=NC(C#N)=C2C=C1OC1=CC=CC=C1 ZCLCWANYQTWHIW-UHFFFAOYSA-N 0.000 claims description 2
- CTADYWAQKGRMMW-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC(CC(O)=O)C)=NC(C#N)=C2C=C1OC1=CC=CC=C1 CTADYWAQKGRMMW-UHFFFAOYSA-N 0.000 claims description 2
- UCHJDAPNJJRRLD-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 UCHJDAPNJJRRLD-UHFFFAOYSA-N 0.000 claims description 2
- JYCKALTXSDGLRG-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenylisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1C1=CC=CC=C1 JYCKALTXSDGLRG-UHFFFAOYSA-N 0.000 claims description 2
- UTAGYFGEPUYWLP-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenylisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC(C#N)=C2C=C1C1=CC=CC=C1 UTAGYFGEPUYWLP-UHFFFAOYSA-N 0.000 claims description 2
- CSOPJEAVQNOFDA-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenylmethoxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OCC1=CC=CC=C1 CSOPJEAVQNOFDA-UHFFFAOYSA-N 0.000 claims description 2
- ABFQAKDMKGAMGM-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenylmethoxyisoquinoline-3-carbonyl)amino]-3-methylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC(C)(CC(O)=O)C)=NC(C#N)=C2C=C1OCC1=CC=CC=C1 ABFQAKDMKGAMGM-UHFFFAOYSA-N 0.000 claims description 2
- SAZUPALACQZLTL-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-phenylsulfanylisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1SC1=CC=CC=C1 SAZUPALACQZLTL-UHFFFAOYSA-N 0.000 claims description 2
- ZRYWQKACQNWRCC-UHFFFAOYSA-N 3-[(1-cyano-4-hydroxy-7-pyridin-3-yloxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CN=C1 ZRYWQKACQNWRCC-UHFFFAOYSA-N 0.000 claims description 2
- SOUXMSDCWRVLNK-UHFFFAOYSA-N 3-[(1-cyano-7-cyclohexyloxy-4-hydroxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1CCCCC1 SOUXMSDCWRVLNK-UHFFFAOYSA-N 0.000 claims description 2
- AKGCWLNZMNXVKU-UHFFFAOYSA-N 3-[(1-cyano-7-cyclohexylsulfonyl-4-hydroxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1S(=O)(=O)C1CCCCC1 AKGCWLNZMNXVKU-UHFFFAOYSA-N 0.000 claims description 2
- ONTIZNOVYGAMON-UHFFFAOYSA-N 3-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=C2C(C)=NC(C(=O)NCCC(O)=O)=C(O)C2=CC=C1OC1=CC=CC=C1 ONTIZNOVYGAMON-UHFFFAOYSA-N 0.000 claims description 2
- BMJJHMFNQHGEHU-UHFFFAOYSA-N 3-[(4-hydroxy-6-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C=1C2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=CC=1OC1=CC=CC=C1 BMJJHMFNQHGEHU-UHFFFAOYSA-N 0.000 claims description 2
- HTVTWRBOFUPCKE-UHFFFAOYSA-N 3-[(4-hydroxy-7-phenoxy-1-phenylisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C=12C=C(OC=3C=CC=CC=3)C=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC=1C1=CC=CC=C1 HTVTWRBOFUPCKE-UHFFFAOYSA-N 0.000 claims description 2
- MBWFVAQJWVNRSE-UHFFFAOYSA-N 3-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC=C2C=C1OC1=CC=CC=C1 MBWFVAQJWVNRSE-UHFFFAOYSA-N 0.000 claims description 2
- YWMFGRNGLFDROK-UHFFFAOYSA-N 3-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2-phenylpropanoic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC=C1C=C2OC1=CC=CC=C1 YWMFGRNGLFDROK-UHFFFAOYSA-N 0.000 claims description 2
- VTVAEEQPTGZMBT-UHFFFAOYSA-N 3-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3-methylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC(C)(CC(O)=O)C)=NC=C2C=C1OC1=CC=CC=C1 VTVAEEQPTGZMBT-UHFFFAOYSA-N 0.000 claims description 2
- CQXMWPJDQXPFRC-UHFFFAOYSA-N 3-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1OC1=CC=CC=C1 CQXMWPJDQXPFRC-UHFFFAOYSA-N 0.000 claims description 2
- ALUZYNOWSWKZRA-UHFFFAOYSA-N 3-[(4-hydroxy-7-phenylisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC=C2C=C1C1=CC=CC=C1 ALUZYNOWSWKZRA-UHFFFAOYSA-N 0.000 claims description 2
- TWNYWJUZZJFTDQ-UHFFFAOYSA-N 3-[(4-hydroxy-7-phenylsulfanylisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC=C2C=C1SC1=CC=CC=C1 TWNYWJUZZJFTDQ-UHFFFAOYSA-N 0.000 claims description 2
- XNHNEVVHEIJPCG-UHFFFAOYSA-N 3-[(4-hydroxy-7-pyridin-2-yloxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1OC1=CC=CC=N1 XNHNEVVHEIJPCG-UHFFFAOYSA-N 0.000 claims description 2
- PXXCPPPHJZXXGB-UHFFFAOYSA-N 3-[(4-hydroxy-7-pyridin-3-yloxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1OC1=CC=CN=C1 PXXCPPPHJZXXGB-UHFFFAOYSA-N 0.000 claims description 2
- GTCQHLGQUOUXDZ-UHFFFAOYSA-N 3-[(7-benzyl-1-cyano-4-hydroxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1CC1=CC=CC=C1 GTCQHLGQUOUXDZ-UHFFFAOYSA-N 0.000 claims description 2
- SIXVEKJOZTWGTE-UHFFFAOYSA-N 3-[(7-benzyl-4-hydroxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC=C2C=C1CC1=CC=CC=C1 SIXVEKJOZTWGTE-UHFFFAOYSA-N 0.000 claims description 2
- JVOFYFIGYZIERX-UHFFFAOYSA-N 3-[(7-cyclohexylsulfonyl-4-hydroxyisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1S(=O)(=O)C1CCCCC1 JVOFYFIGYZIERX-UHFFFAOYSA-N 0.000 claims description 2
- LIPLTYRTHVKYLT-UHFFFAOYSA-N 3-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]-5-methylhexanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(CC(C)C)CC(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 LIPLTYRTHVKYLT-UHFFFAOYSA-N 0.000 claims description 2
- WTLXLQBMAJRSSQ-UHFFFAOYSA-N 3-[[1-(5-fluoropyridin-3-yl)-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C=12C=C(OC=3C=CC=CC=3)C=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC=1C1=CN=CC(F)=C1 WTLXLQBMAJRSSQ-UHFFFAOYSA-N 0.000 claims description 2
- QTKYWOJOSRQCSQ-UHFFFAOYSA-N 3-[[1-cyano-4-hydroxy-6-(2-methylphenoxy)isoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound CC1=CC=CC=C1OC1=CC=C(C(=NC(C(=O)NCC(C)(C)C(O)=O)=C2O)C#N)C2=C1 QTKYWOJOSRQCSQ-UHFFFAOYSA-N 0.000 claims description 2
- RVSYSFBUEFXXLR-UHFFFAOYSA-N 3-[[1-cyano-4-hydroxy-7-(2-methoxyphenoxy)isoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound COC1=CC=CC=C1OC1=CC=C(C(O)=C(N=C2C#N)C(=O)NCC(C)(C)C(O)=O)C2=C1 RVSYSFBUEFXXLR-UHFFFAOYSA-N 0.000 claims description 2
- WLJNGALROCQDHT-UHFFFAOYSA-N 3-[[1-cyano-4-hydroxy-7-(2-phenylethyl)isoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1CCC1=CC=CC=C1 WLJNGALROCQDHT-UHFFFAOYSA-N 0.000 claims description 2
- ZOYRXGFBRVVDRN-UHFFFAOYSA-N 3-[[1-cyano-4-hydroxy-7-(4-methoxyphenoxy)isoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC(OC)=CC=C1OC1=CC=C(C(O)=C(N=C2C#N)C(=O)NCC(C)(C)C(O)=O)C2=C1 ZOYRXGFBRVVDRN-UHFFFAOYSA-N 0.000 claims description 2
- YLAYKCQTUJKINN-UHFFFAOYSA-N 3-[[1-cyano-4-hydroxy-7-(4-methoxyphenoxy)isoquinoline-3-carbonyl]amino]-3-methylbutanoic acid Chemical compound C1=CC(OC)=CC=C1OC1=CC=C(C(O)=C(N=C2C#N)C(=O)NC(C)(C)CC(O)=O)C2=C1 YLAYKCQTUJKINN-UHFFFAOYSA-N 0.000 claims description 2
- UPCTVPDBBQWTLO-UHFFFAOYSA-N 3-[[1-cyano-4-hydroxy-7-(4-methylphenoxy)isoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC(C)=CC=C1OC1=CC=C(C(O)=C(N=C2C#N)C(=O)NCC(C)(C)C(O)=O)C2=C1 UPCTVPDBBQWTLO-UHFFFAOYSA-N 0.000 claims description 2
- KLWZJJXXBFPBBY-UHFFFAOYSA-N 3-[[1-cyano-4-hydroxy-7-(phenylcarbamoylamino)isoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1NC(=O)NC1=CC=CC=C1 KLWZJJXXBFPBBY-UHFFFAOYSA-N 0.000 claims description 2
- QRKPIEXQMYXMLU-UHFFFAOYSA-N 3-[[1-cyano-6-(2,6-dimethylphenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]propanoic acid Chemical compound CC1=CC=CC(C)=C1OC1=CC=C(C(=NC(C(=O)NCCC(O)=O)=C2O)C#N)C2=C1 QRKPIEXQMYXMLU-UHFFFAOYSA-N 0.000 claims description 2
- FIULMQMFLBBFGD-UHFFFAOYSA-N 3-[[1-cyano-7-(2,6-difluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=C(F)C=CC=C1F FIULMQMFLBBFGD-UHFFFAOYSA-N 0.000 claims description 2
- KWBGGTSHDPTZED-UHFFFAOYSA-N 3-[[1-cyano-7-(2,6-difluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]-2-cyclopropylpropanoic acid Chemical compound C1CC1C(C(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=C(F)C=CC=C1F KWBGGTSHDPTZED-UHFFFAOYSA-N 0.000 claims description 2
- BCYWFZDQEIWSRP-UHFFFAOYSA-N 3-[[1-cyano-7-(2-ethylphenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound CCC1=CC=CC=C1OC1=CC=C(C(O)=C(N=C2C#N)C(=O)NCC(C)(C)C(O)=O)C2=C1 BCYWFZDQEIWSRP-UHFFFAOYSA-N 0.000 claims description 2
- MZEXWOZBKFVOHY-UHFFFAOYSA-N 3-[[1-cyano-7-(2-fluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1F MZEXWOZBKFVOHY-UHFFFAOYSA-N 0.000 claims description 2
- UVKYKSIYQOGGRM-UHFFFAOYSA-N 3-[[1-cyano-7-(4-fluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=C(F)C=C1 UVKYKSIYQOGGRM-UHFFFAOYSA-N 0.000 claims description 2
- ZFKJTWWTFDTGHS-UHFFFAOYSA-N 3-[[1-cyano-7-(4-fluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]-2-cyclopropylpropanoic acid Chemical compound C1CC1C(C(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=C(F)C=C1 ZFKJTWWTFDTGHS-UHFFFAOYSA-N 0.000 claims description 2
- SYDRETOAEIYGBU-UHFFFAOYSA-N 3-[[1-cyano-7-(4-fluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]-3-methylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC(C)(CC(O)=O)C)=NC(C#N)=C2C=C1OC1=CC=C(F)C=C1 SYDRETOAEIYGBU-UHFFFAOYSA-N 0.000 claims description 2
- CLAIYYDDLZHNOH-UHFFFAOYSA-N 3-[[4-hydroxy-1-[2-methyl-5-(trifluoromethyl)pyrazol-3-yl]-7-phenoxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound Cn1nc(cc1-c1nc(C(=O)NCC(C)(C)C(O)=O)c(O)c2ccc(Oc3ccccc3)cc12)C(F)(F)F CLAIYYDDLZHNOH-UHFFFAOYSA-N 0.000 claims description 2
- MWTHTDNUNOIXLR-UHFFFAOYSA-N 3-[[4-hydroxy-7-(4-methoxyphenoxy)isoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC(OC)=CC=C1OC1=CC=C(C(O)=C(N=C2)C(=O)NCC(C)(C)C(O)=O)C2=C1 MWTHTDNUNOIXLR-UHFFFAOYSA-N 0.000 claims description 2
- VNDPTXLBKNLABX-UHFFFAOYSA-N 3-[[4-hydroxy-7-(phenylcarbamoylamino)isoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1NC(=O)NC1=CC=CC=C1 VNDPTXLBKNLABX-UHFFFAOYSA-N 0.000 claims description 2
- ORSGHEQBIQWLNI-UHFFFAOYSA-N 3-[[4-hydroxy-7-[(4-methoxyphenyl)methylamino]isoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC(OC)=CC=C1CNC1=CC=C(C(O)=C(N=C2)C(=O)NCC(C)(C)C(O)=O)C2=C1 ORSGHEQBIQWLNI-UHFFFAOYSA-N 0.000 claims description 2
- SOJUNNCQLHXEQY-UHFFFAOYSA-N 3-[[4-hydroxy-7-phenoxy-1-(trifluoromethyl)isoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC(C(F)(F)F)=C2C=C1OC1=CC=CC=C1 SOJUNNCQLHXEQY-UHFFFAOYSA-N 0.000 claims description 2
- NDEWXUUQBMZATN-UHFFFAOYSA-N 3-[[7-(2-chloro-4-fluorophenoxy)-1-cyano-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=C(F)C=C1Cl NDEWXUUQBMZATN-UHFFFAOYSA-N 0.000 claims description 2
- CPJOTBCUFSIFTG-UHFFFAOYSA-N 3-[[7-(2-chloro-4-fluorophenoxy)-1-cyano-4-hydroxyisoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC(C#N)=C2C=C1OC1=CC=C(F)C=C1Cl CPJOTBCUFSIFTG-UHFFFAOYSA-N 0.000 claims description 2
- DBYWIXVTXJEQOH-UHFFFAOYSA-N 3-[[7-(2-chloro-5-fluorophenoxy)-1-cyano-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC(F)=CC=C1Cl DBYWIXVTXJEQOH-UHFFFAOYSA-N 0.000 claims description 2
- CQUBLEKDHAJRGI-UHFFFAOYSA-N 3-[[7-(3-chlorophenoxy)-1-cyano-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC(Cl)=C1 CQUBLEKDHAJRGI-UHFFFAOYSA-N 0.000 claims description 2
- BTORTRFPTVLRGK-UHFFFAOYSA-N 3-[[7-(4-chloro-3-fluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC=C2C=C1OC1=CC=C(Cl)C(F)=C1 BTORTRFPTVLRGK-UHFFFAOYSA-N 0.000 claims description 2
- RNXRRHMSZOBLAT-UHFFFAOYSA-N 3-[[7-(4-chlorophenoxy)-1-cyano-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=C(Cl)C=C1 RNXRRHMSZOBLAT-UHFFFAOYSA-N 0.000 claims description 2
- XPOYEEHRTKOESN-UHFFFAOYSA-N 3-[[7-(4-fluorophenyl)-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC=C2C=C1C1=CC=C(F)C=C1 XPOYEEHRTKOESN-UHFFFAOYSA-N 0.000 claims description 2
- ITHBDAHRXIWOKN-UHFFFAOYSA-N 3-[[7-(4-fluorophenyl)-4-hydroxyisoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1C1=CC=C(F)C=C1 ITHBDAHRXIWOKN-UHFFFAOYSA-N 0.000 claims description 2
- FJEHFGCVLOBNDL-UHFFFAOYSA-N 3-[[7-(benzylcarbamoylamino)-1-cyano-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1NC(=O)NCC1=CC=CC=C1 FJEHFGCVLOBNDL-UHFFFAOYSA-N 0.000 claims description 2
- PUCPBWDXBCNSKJ-UHFFFAOYSA-N 3-[[7-(benzylcarbamoylamino)-4-hydroxyisoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1NC(=O)NCC1=CC=CC=C1 PUCPBWDXBCNSKJ-UHFFFAOYSA-N 0.000 claims description 2
- FLJUQTWIVUYHJE-UHFFFAOYSA-N 3-[[7-(cyclohexylcarbamoylamino)-4-hydroxyisoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1NC(=O)NC1CCCCC1 FLJUQTWIVUYHJE-UHFFFAOYSA-N 0.000 claims description 2
- SCDMCQNNBLFKFT-UHFFFAOYSA-N 3-[[7-[(4-fluorobenzoyl)amino]-4-hydroxyisoquinoline-3-carbonyl]amino]-2,2-dimethylpropanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)C(O)=O)=NC=C2C=C1NC(=O)C1=CC=C(F)C=C1 SCDMCQNNBLFKFT-UHFFFAOYSA-N 0.000 claims description 2
- WATLWSKURSMVMI-UHFFFAOYSA-N 3-[[7-[(4-fluorobenzoyl)amino]-4-hydroxyisoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1NC(=O)C1=CC=C(F)C=C1 WATLWSKURSMVMI-UHFFFAOYSA-N 0.000 claims description 2
- XTAFVBZBDXUFHD-UHFFFAOYSA-N 3-[[7-[(4-fluorophenyl)carbamoylamino]-4-hydroxyisoquinoline-3-carbonyl]amino]propanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=C2C=C1NC(=O)NC1=CC=C(F)C=C1 XTAFVBZBDXUFHD-UHFFFAOYSA-N 0.000 claims description 2
- ZONUPWOYJLMWNR-UHFFFAOYSA-N 4-[(1-cyano-4-hydroxy-2-oxido-7-phenoxyisoquinolin-2-ium-3-carbonyl)amino]butanoic acid Chemical compound C1=C2C(C#N)=[N+]([O-])C(C(=O)NCCCC(=O)O)=C(O)C2=CC=C1OC1=CC=CC=C1 ZONUPWOYJLMWNR-UHFFFAOYSA-N 0.000 claims description 2
- FIJICXIAJJALHP-UHFFFAOYSA-N 4-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2,2-dimethylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 FIJICXIAJJALHP-UHFFFAOYSA-N 0.000 claims description 2
- HHMPOMPVMCXSIV-UHFFFAOYSA-N 4-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-3,3-dimethylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCC(C)(C)CC(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 HHMPOMPVMCXSIV-UHFFFAOYSA-N 0.000 claims description 2
- MZMXPZLIYKKHIZ-UHFFFAOYSA-N 4-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(=O)O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 MZMXPZLIYKKHIZ-UHFFFAOYSA-N 0.000 claims description 2
- HOZJGVRZKLKDAT-UHFFFAOYSA-N 4-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NC(CCC(O)=O)C)=NC(C#N)=C2C=C1OC1=CC=CC=C1 HOZJGVRZKLKDAT-UHFFFAOYSA-N 0.000 claims description 2
- HSBHWCUVYXNGIH-UHFFFAOYSA-N 4-[(4-hydroxy-6-phenoxyisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C=1C2=C(O)C(C(=O)NCCCC(=O)O)=NC=C2C=CC=1OC1=CC=CC=C1 HSBHWCUVYXNGIH-UHFFFAOYSA-N 0.000 claims description 2
- VOZXLVQTKVZELE-UHFFFAOYSA-N 4-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2,2-dimethylbutanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCC(C)(C)C(O)=O)=NC=C2C=C1OC1=CC=CC=C1 VOZXLVQTKVZELE-UHFFFAOYSA-N 0.000 claims description 2
- FTCUDOFYRBMPLE-UHFFFAOYSA-N 4-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(=O)O)=NC=C2C=C1OC1=CC=CC=C1 FTCUDOFYRBMPLE-UHFFFAOYSA-N 0.000 claims description 2
- GMCNRZVDZINNGA-UHFFFAOYSA-N 4-[(4-hydroxy-7-phenylsulfanylisoquinoline-3-carbonyl)amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(=O)O)=NC=C2C=C1SC1=CC=CC=C1 GMCNRZVDZINNGA-UHFFFAOYSA-N 0.000 claims description 2
- SEEAXIMDRVUIOI-UHFFFAOYSA-N 4-[[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]oxane-4-carboxylic acid Chemical compound N=1C(C#N)=C2C=C(OC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCOCC1 SEEAXIMDRVUIOI-UHFFFAOYSA-N 0.000 claims description 2
- PBBJYCCOUZDWCZ-UHFFFAOYSA-N 4-[[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]methyl]oxane-4-carboxylic acid Chemical compound N=1C=C2C=C(OC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NCC1(C(=O)O)CCOCC1 PBBJYCCOUZDWCZ-UHFFFAOYSA-N 0.000 claims description 2
- KRDJPAJCSJQTCY-UHFFFAOYSA-N 4-[[1-cyano-6-(2,6-dimethylphenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]butanoic acid Chemical compound CC1=CC=CC(C)=C1OC1=CC=C(C(=NC(C(=O)NCCCC(O)=O)=C2O)C#N)C2=C1 KRDJPAJCSJQTCY-UHFFFAOYSA-N 0.000 claims description 2
- SHOXZWDCYYTFQU-UHFFFAOYSA-N 4-[[4-hydroxy-7-(phenylcarbamoylamino)isoquinoline-3-carbonyl]amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(=O)O)=NC=C2C=C1NC(=O)NC1=CC=CC=C1 SHOXZWDCYYTFQU-UHFFFAOYSA-N 0.000 claims description 2
- ZCPXHSRUGVQBOS-UHFFFAOYSA-N 4-[[7-(4-fluorophenyl)-4-hydroxyisoquinoline-3-carbonyl]amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(=O)O)=NC=C2C=C1C1=CC=C(F)C=C1 ZCPXHSRUGVQBOS-UHFFFAOYSA-N 0.000 claims description 2
- MSFVNLZXZIUXDT-UHFFFAOYSA-N 4-[[7-(benzylcarbamoylamino)-4-hydroxyisoquinoline-3-carbonyl]amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(=O)O)=NC=C2C=C1NC(=O)NCC1=CC=CC=C1 MSFVNLZXZIUXDT-UHFFFAOYSA-N 0.000 claims description 2
- RYWWCOCNATUMPV-UHFFFAOYSA-N 4-[[7-(cyclohexylcarbamoylamino)-4-hydroxyisoquinoline-3-carbonyl]amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(=O)O)=NC=C2C=C1NC(=O)NC1CCCCC1 RYWWCOCNATUMPV-UHFFFAOYSA-N 0.000 claims description 2
- PYAQKOCTUZPLMB-UHFFFAOYSA-N 4-[[7-[(4-fluorobenzoyl)amino]-4-hydroxyisoquinoline-3-carbonyl]amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(=O)O)=NC=C2C=C1NC(=O)C1=CC=C(F)C=C1 PYAQKOCTUZPLMB-UHFFFAOYSA-N 0.000 claims description 2
- DDUNMUYEKBOLSN-UHFFFAOYSA-N 4-[[7-[(4-fluorophenyl)carbamoylamino]-4-hydroxyisoquinoline-3-carbonyl]amino]butanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(=O)O)=NC=C2C=C1NC(=O)NC1=CC=C(F)C=C1 DDUNMUYEKBOLSN-UHFFFAOYSA-N 0.000 claims description 2
- PLDDEHBMYMKSPF-UHFFFAOYSA-N 5-[(1-cyano-4-hydroxy-6-phenoxyisoquinoline-3-carbonyl)amino]pentanoic acid Chemical compound C=1C2=C(O)C(C(=O)NCCCCC(=O)O)=NC(C#N)=C2C=CC=1OC1=CC=CC=C1 PLDDEHBMYMKSPF-UHFFFAOYSA-N 0.000 claims description 2
- GTHFKJIIRVXYES-UHFFFAOYSA-N 5-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]-2,2-dimethylpentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCC(C)(C)C(O)=O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 GTHFKJIIRVXYES-UHFFFAOYSA-N 0.000 claims description 2
- RSKFOCLJBCRDEJ-UHFFFAOYSA-N 5-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCCC(=O)O)=NC(C#N)=C2C=C1OC1=CC=CC=C1 RSKFOCLJBCRDEJ-UHFFFAOYSA-N 0.000 claims description 2
- JUXYNOAVDKQARA-UHFFFAOYSA-N 5-[(4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCCC(=O)O)=NC=C2C=C1OC1=CC=CC=C1 JUXYNOAVDKQARA-UHFFFAOYSA-N 0.000 claims description 2
- FEHZWPNAZATNFN-UHFFFAOYSA-N 5-[(4-hydroxy-7-phenylsulfanylisoquinoline-3-carbonyl)amino]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCCC(=O)O)=NC=C2C=C1SC1=CC=CC=C1 FEHZWPNAZATNFN-UHFFFAOYSA-N 0.000 claims description 2
- JOQVQJRZNHTZAY-UHFFFAOYSA-N 5-[(7-anilino-4-hydroxyisoquinoline-3-carbonyl)amino]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCCC(=O)O)=NC=C2C=C1NC1=CC=CC=C1 JOQVQJRZNHTZAY-UHFFFAOYSA-N 0.000 claims description 2
- VYKDLLJGOJTKDV-UHFFFAOYSA-N 5-[[1-(5-fluoropyridin-3-yl)-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl]amino]pentanoic acid Chemical compound C=12C=C(OC=3C=CC=CC=3)C=CC2=C(O)C(C(=O)NCCCCC(=O)O)=NC=1C1=CN=CC(F)=C1 VYKDLLJGOJTKDV-UHFFFAOYSA-N 0.000 claims description 2
- QTGCKPZNEUANAZ-UHFFFAOYSA-N 5-[[1-cyano-6-(2,6-dimethylphenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]pentanoic acid Chemical compound CC1=CC=CC(C)=C1OC1=CC=C(C(=NC(C(=O)NCCCCC(O)=O)=C2O)C#N)C2=C1 QTGCKPZNEUANAZ-UHFFFAOYSA-N 0.000 claims description 2
- PHJRXUKBVHDOKV-UHFFFAOYSA-N 5-[[4-hydroxy-7-[(4-methoxyphenyl)methylamino]isoquinoline-3-carbonyl]amino]pentanoic acid Chemical compound C1=CC(OC)=CC=C1CNC1=CC=C(C(O)=C(N=C2)C(=O)NCCCCC(O)=O)C2=C1 PHJRXUKBVHDOKV-UHFFFAOYSA-N 0.000 claims description 2
- ORJNCLZDFNJMRS-UHFFFAOYSA-N 5-[[7-(2,6-difluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCCC(=O)O)=NC=C2C=C1OC1=C(F)C=CC=C1F ORJNCLZDFNJMRS-UHFFFAOYSA-N 0.000 claims description 2
- GOOTUHUWMKJRKO-UHFFFAOYSA-N 5-[[7-(2-chloro-4-fluorophenoxy)-1-cyano-4-hydroxyisoquinoline-3-carbonyl]amino]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCCC(=O)O)=NC(C#N)=C2C=C1OC1=CC=C(F)C=C1Cl GOOTUHUWMKJRKO-UHFFFAOYSA-N 0.000 claims description 2
- CXCKWUPISMEDBQ-UHFFFAOYSA-N 5-[[7-(4-fluorophenyl)-4-hydroxyisoquinoline-3-carbonyl]amino]pentanoic acid Chemical compound C1=CC2=C(O)C(C(=O)NCCCCC(=O)O)=NC=C2C=C1C1=CC=C(F)C=C1 CXCKWUPISMEDBQ-UHFFFAOYSA-N 0.000 claims description 2
- 206010019280 Heart failures Diseases 0.000 claims description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 2
- HBZKEQAJFYDEJB-UHFFFAOYSA-N OC(=O)C1CCC(CC1)NC(=O)c1nc(C#N)c2cc(Oc3ccccc3)ccc2c1O Chemical compound OC(=O)C1CCC(CC1)NC(=O)c1nc(C#N)c2cc(Oc3ccccc3)ccc2c1O HBZKEQAJFYDEJB-UHFFFAOYSA-N 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 2
- 206010009887 colitis Diseases 0.000 claims description 2
- 230000007850 degeneration Effects 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 208000019622 heart disease Diseases 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 208000017169 kidney disease Diseases 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 210000002363 skeletal muscle cell Anatomy 0.000 claims description 2
- UVZAJYRUIDEZHA-UHFFFAOYSA-N tert-butyl 3-[(1-cyano-4-hydroxy-7-pyridin-3-yloxyisoquinoline-3-carbonyl)amino]-2-cyclopropylpropanoate Chemical compound C1CC1C(C(=O)OC(C)(C)C)CNC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CN=C1 UVZAJYRUIDEZHA-UHFFFAOYSA-N 0.000 claims description 2
- 150000001721 carbon Chemical group 0.000 claims 4
- 150000001408 amides Chemical class 0.000 claims 2
- 125000005162 aryl oxy carbonyl amino group Chemical group 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims 2
- 125000005368 heteroarylthio group Chemical group 0.000 claims 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 2
- WRHGNOBRJVLDQS-UHFFFAOYSA-N 3-[[1-cyano-7-(2-fluorophenoxy)-4-hydroxyisoquinoline-3-carbonyl]amino]-2-cyclopropylpropanoic acid Chemical compound C1CC1C(C(=O)O)CNC(=O)C(C(=C1C=C2)O)=NC(C#N)=C1C=C2OC1=CC=CC=C1F WRHGNOBRJVLDQS-UHFFFAOYSA-N 0.000 claims 1
- CIEXUDARNJDRJD-UHFFFAOYSA-N 5-[[4-hydroxy-7-(4-methoxyphenoxy)isoquinoline-3-carbonyl]amino]pentanoic acid Chemical compound C1=CC(OC)=CC=C1OC1=CC=C(C(O)=C(N=C2)C(=O)NCCCCC(O)=O)C2=C1 CIEXUDARNJDRJD-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000005518 carboxamido group Chemical group 0.000 claims 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 description 2
- ZJGXGPMCAJOKHB-UHFFFAOYSA-N 1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carboxamide Chemical compound NC(=O)C1=C(O)C2=CC=C(OC3=CC=CC=C3)C=C2C(=N1)C#N ZJGXGPMCAJOKHB-UHFFFAOYSA-N 0.000 description 1
- POSNWIHEBUHYHY-UHFFFAOYSA-N 2-[1-[(1-cyano-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)amino]cyclobutyl]acetic acid Chemical compound N=1C(C#N)=C2C=C(OC=3C=CC=CC=3)C=CC2=C(O)C=1C(=O)NC1(CC(=O)O)CCC1 POSNWIHEBUHYHY-UHFFFAOYSA-N 0.000 description 1
- YARCNJBDGQYTSQ-UHFFFAOYSA-N 3-[(4-hydroxy-7-phenoxy-1-phenylisoquinoline-3-carbonyl)amino]propanoic acid Chemical compound C=12C=C(OC=3C=CC=CC=3)C=CC2=C(O)C(C(=O)NCCC(=O)O)=NC=1C1=CC=CC=C1 YARCNJBDGQYTSQ-UHFFFAOYSA-N 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- WRWYGOVGIGCDLE-UHFFFAOYSA-N [O]c1ccccc1F Chemical group [O]c1ccccc1F WRWYGOVGIGCDLE-UHFFFAOYSA-N 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261609022P | 2012-03-09 | 2012-03-09 | |
| US61/609,022 | 2012-03-09 | ||
| PCT/US2013/029912 WO2013134660A1 (en) | 2012-03-09 | 2013-03-08 | 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017047346A Division JP2017101089A (ja) | 2012-03-09 | 2017-03-13 | Ｈｉｆヒドロキシラーゼインヒビターとしての４−ヒドロキシ−イソキノリン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015509543A JP2015509543A (ja) | 2015-03-30 |
| JP2015509543A5 true JP2015509543A5 (OSRAM) | 2016-04-28 |
| JP6129217B2 JP6129217B2 (ja) | 2017-05-17 |
Family
ID=48014301
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014561149A Active JP6129217B2 (ja) | 2012-03-09 | 2013-03-08 | Ｈｉｆヒドロキシラーゼインヒビターとしての４−ヒドロキシ−イソキノリン化合物 |
| JP2017047346A Pending JP2017101089A (ja) | 2012-03-09 | 2017-03-13 | Ｈｉｆヒドロキシラーゼインヒビターとしての４−ヒドロキシ−イソキノリン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017047346A Pending JP2017101089A (ja) | 2012-03-09 | 2017-03-13 | Ｈｉｆヒドロキシラーゼインヒビターとしての４−ヒドロキシ−イソキノリン化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9409892B2 (OSRAM) |
| EP (1) | EP2834220B1 (OSRAM) |
| JP (2) | JP6129217B2 (OSRAM) |
| CN (1) | CN104470899B (OSRAM) |
| AU (1) | AU2013229922B2 (OSRAM) |
| CA (1) | CA2866556C (OSRAM) |
| IL (1) | IL234544A (OSRAM) |
| NZ (1) | NZ700760A (OSRAM) |
| SG (1) | SG11201405574UA (OSRAM) |
| WO (1) | WO2013134660A1 (OSRAM) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102718708A (zh) | 2003-06-06 | 2012-10-10 | 菲布罗根有限公司 | 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途 |
| CN105037323A (zh) | 2008-11-14 | 2015-11-11 | 菲布罗根有限公司 | 作为hif羟化酶抑制剂的苯并噻喃衍生物 |
| US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
| ES2631655T3 (es) | 2012-07-16 | 2017-09-01 | Fibrogen, Inc. | Procedimiento para fabricar compuestos de isoquinolina |
| KR20220164068A (ko) | 2012-07-16 | 2022-12-12 | 피브로겐, 인크. | 프롤릴 하이드록실라제 억제제 [(4-하이드록시-1-메틸-7-페녹시-아이소퀴놀린-3-카보닐)-아미노]-아세트산의 결정형 |
| LT3003284T (lt) | 2013-06-06 | 2020-04-27 | Fibrogen, Inc. | Hif hidroksilazės inhibitoriaus farmacinės kompozicijos |
| WO2015054579A1 (en) * | 2013-10-11 | 2015-04-16 | Isis Pharmaceuticals, Inc. | Treatment of acute kidney injury with phd1 modulators |
| WO2016034108A1 (zh) | 2014-09-02 | 2016-03-10 | 广东东阳光药业有限公司 | 喹啉酮类化合物及其应用 |
| CN106146395B (zh) | 2015-03-27 | 2019-01-01 | 沈阳三生制药有限责任公司 | 3-羟基吡啶化合物、其制备方法及其制药用途 |
| CN106146490B (zh) * | 2015-03-27 | 2018-10-23 | 沈阳三生制药有限责任公司 | 被芳氧基或杂芳氧基取代的5-羟基-1,7-萘啶化合物、其制备方法及其制药用途 |
| CN105367435A (zh) * | 2015-12-03 | 2016-03-02 | 张伟 | 一种β-丙氨酸叔丁酯盐酸盐的制备方法 |
| CN107188875B (zh) * | 2016-03-15 | 2020-11-10 | 联化科技股份有限公司 | 一种取代苯酞类化合物的制备方法及其中间体 |
| CN106478503A (zh) * | 2016-09-29 | 2017-03-08 | 上海勋和医药科技有限公司 | Roxadustat中间体的制备方法 |
| JP2019529522A (ja) | 2016-10-10 | 2019-10-17 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ＲＯＲγ調節因子としての三環式スルホン類 |
| CN107954931B (zh) * | 2016-10-17 | 2021-06-22 | 上海医药集团青岛国风药业股份有限公司 | 一种诺得司他的制备方法 |
| WO2018140186A1 (en) | 2017-01-28 | 2018-08-02 | Kingchem Life Science Llc | A process for preparing 5-phenoxy-1(3h)isobenzofuranone |
| TW201920108A (zh) * | 2017-09-25 | 2019-06-01 | 日商武田藥品工業有限公司 | N-(氰基取代之苄基或吡啶基甲基)-3-羥基吡啶醯胺衍生物 |
| CN108084090B (zh) * | 2017-12-20 | 2020-03-17 | 北京六合宁远科技有限公司 | 一种药物中间体含氮杂环的溴代化合物的合成方法 |
| CN112679431B (zh) * | 2019-10-18 | 2023-05-05 | 上海迪赛诺化学制药有限公司 | 一种制备异喹啉酮类化合物的方法 |
| US20230112619A1 (en) * | 2019-10-18 | 2023-04-13 | Shanghai Desano Chemical Pharmaceutical Co., Ltd. | Method for preparing isoquinolinone compounds |
| CN112679430B (zh) * | 2019-10-18 | 2023-05-05 | 上海迪赛诺化学制药有限公司 | 一种制备异喹啉酮类化合物的方法 |
| CN113754569B (zh) * | 2020-06-04 | 2024-07-02 | 四川国为制药有限公司 | 一种中间体化合物及其制备方法和用途 |
| CA3235718A1 (en) * | 2021-10-28 | 2023-05-04 | Insilico Medicine Ip Limited | Prolyl hydroxylase domain-containing protein (phd) inhibitors and uses thereof |
| CN118715015A (zh) * | 2021-12-17 | 2024-09-27 | 阿克比治疗有限公司 | 选择性phd1抑制剂化合物、组合物和使用方法 |
| EP4448493A1 (en) * | 2021-12-17 | 2024-10-23 | Akebia Therapeutics, Inc. | Picolinamide compounds as selective phd1 inhibitors, compositions, and methods of use |
| CA3248087A1 (en) * | 2022-01-13 | 2023-07-20 | Fibrogen, Inc. | TREATMENT OF CONGESTIVE HEART FAILURE |
| WO2024138317A1 (zh) * | 2022-12-26 | 2024-07-04 | 中国科学院广州生物医药与健康研究院 | 一种甲状腺激素受体β激动剂化合物及其制备方法和应用 |
| WO2024222890A1 (en) * | 2023-04-28 | 2024-10-31 | Insilico Medicine Ip Limited | Prolyl hydroxylase domain-containing protein (phd) inhibitors, combinations and uses thereof |
| KR20250174914A (ko) * | 2023-04-28 | 2025-12-15 | 인실리코 메디신 아이피 리미티드 | 결정질 프롤릴 하이드록실라제 도메인 포함 단백질(phd) 억제제 및 이의 용도 |
| CN121057737A (zh) * | 2023-04-28 | 2025-12-02 | 英矽智能科技知识产权有限公司 | 含脯氨酰羟化酶结构域的蛋白质(phd)抑制剂结晶及其用途 |
| CN117486797A (zh) * | 2023-11-23 | 2024-02-02 | 传健生物医药(厦门)有限公司 | 一种罗沙司他关键中间体及罗沙司他的制备方法 |
| WO2025252553A1 (en) | 2024-06-04 | 2025-12-11 | Syngenta Crop Protection Ag | Pesticidally-active 2,2-dihalocyclopropyl compounds |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4036964A (en) | 1973-10-11 | 1977-07-19 | Beecham Group Limited | Isocarbostyril-3-carboxylic acid derivatives for the prophylaxis of asthma, hayfever and rhinitis |
| US3989704A (en) | 1973-10-30 | 1976-11-02 | Sandoz, Inc. | 3-Substituted-4-aryl isoquinolines |
| DE2818423A1 (de) | 1978-04-27 | 1979-11-08 | Hoechst Ag | Neue isochinolinderivate und verfahren zu ihrer herstellung |
| DE3233424A1 (de) | 1982-09-09 | 1984-03-15 | Hoechst Ag, 6230 Frankfurt | Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
| US4559403A (en) | 1983-05-19 | 1985-12-17 | Hoffmann-La Roche Inc. | Substituted isoquinolines |
| US4584379A (en) | 1985-01-22 | 1986-04-22 | Merrell Dow Pharmaceuticals Inc. | Isoquinoline thromboxane synthetase inhibitors |
| US4822800A (en) | 1986-06-09 | 1989-04-18 | Ortho Pharmaceutical Corporation | Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties |
| US4966906A (en) | 1987-11-27 | 1990-10-30 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-isoquinolinecarboxamides |
| US4952588A (en) | 1987-11-27 | 1990-08-28 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-quinoline-and 1-aryl-3-isoquinoline-carboxamides |
| ES2101420T3 (es) * | 1993-11-02 | 1997-07-01 | Hoechst Ag | Esteres-amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos. |
| ATE149486T1 (de) | 1993-11-02 | 1997-03-15 | Hoechst Ag | Substituierte heterocyclische carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel |
| CA2138929A1 (en) | 1993-12-30 | 1995-07-01 | Klaus Weidmann | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| AU4515696A (en) | 1994-12-12 | 1996-07-03 | Merck & Co., Inc. | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase |
| IL135495A (en) | 1995-09-28 | 2002-12-01 | Hoechst Ag | Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid |
| US6130231A (en) | 1996-11-27 | 2000-10-10 | Dupont Pharmaceuticals | Integrin receptor antagonists |
| DE19746287A1 (de) | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| FR2779963A1 (fr) | 1998-06-22 | 1999-12-24 | Centre Nat Rech Scient | Utilisation d'un compose possedant une affinite pour le recepteur mitochondrial des benzodiazepines en therapie du cancer |
| IT1302677B1 (it) | 1998-10-15 | 2000-09-29 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
| AU4802500A (en) | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
| IT1320162B1 (it) | 2000-02-09 | 2003-11-18 | Rotta Research Lab | Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico. |
| FI20002044A0 (fi) | 2000-09-15 | 2000-09-15 | Orion Yhtymae Oyj | Comt-entsyymiä estäviä naftaleenijohdannaisia |
| DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| US6716866B2 (en) | 2001-06-13 | 2004-04-06 | Genesoft Pharmaceuticals, Inc. | Aryl-benzimidazole compounds having antiinfective activity |
| JP2005505507A (ja) | 2001-06-13 | 2005-02-24 | ジーンソフト ファーマシューティカルズ インコーポレイテッド | 抗感染活性を有するイソキノリン化合物 |
| US6762318B2 (en) | 2001-12-03 | 2004-07-13 | Novo Nordisk A/S | Glucagon antagonists |
| JP2005524612A (ja) | 2001-12-06 | 2005-08-18 | ファイブローゲン、インコーポレーテッド | 内因性エリスロポエチン（ｅｐｏ）を増加させる方法 |
| US8124582B2 (en) | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US7618940B2 (en) | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| CN102718708A (zh) | 2003-06-06 | 2012-10-10 | 菲布罗根有限公司 | 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途 |
| US20060251638A1 (en) | 2003-06-06 | 2006-11-09 | Volkmar Guenzler-Pukall | Cytoprotection through the use of hif hydroxylase inhibitors |
| CA2532064A1 (en) | 2003-07-15 | 2005-02-03 | Merck & Co., Inc. | Hydroxypyridine cgrp receptor antagonists |
| WO2005011696A1 (en) | 2003-08-01 | 2005-02-10 | Fibrogen, Inc. | Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| US7208601B2 (en) | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
| JP2007501844A (ja) | 2003-08-08 | 2007-02-01 | トランス テック ファーマ，インコーポレイテッド | アリール及びヘテロアリール化合物、組成物並びに使用方法 |
| ES2332798T3 (es) | 2004-05-28 | 2010-02-12 | Fibrogen, Inc. | Ensayo de actividad de la prolil hidroxilasa de hif. |
| JP4792048B2 (ja) | 2005-03-02 | 2011-10-12 | ファイブロゲン インコーポレイティッド | チエノピリジン化合物およびその使用方法 |
| US20060276477A1 (en) | 2005-06-06 | 2006-12-07 | Fibrogen, Inc. | Treatment method for anemia |
| CN101242817B (zh) | 2005-06-15 | 2016-08-31 | 菲布罗根公司 | HIF1α调节剂在治疗癌症中的用途 |
| WO2007082899A1 (en) | 2006-01-17 | 2007-07-26 | Vib Vzw | Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration |
| RU2457204C2 (ru) * | 2006-01-27 | 2012-07-27 | Файброджен, Инк. | Цианоизохинолиновые соединения (варианты), фармацевтическая композиция на их основе, способ ингибирования активности гидроксилазы гипоксия-индуцибельного фактора (hif) и способ лечения и/или профилактики состояния, связанного с hif, и/или состояния, связанного с эритропоэтином, и/или анемии |
| AU2007234408B2 (en) | 2006-04-04 | 2011-05-19 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as HIF modulators |
| US7713986B2 (en) | 2006-06-15 | 2010-05-11 | Fibrogen, Inc. | Compounds and methods for treatment of chemotherapy-induced anemia |
| US20070293575A1 (en) | 2006-06-15 | 2007-12-20 | Fibrogen, Inc. | Compounds and methods for treatment of cancer-related anemia |
| DK3026044T3 (en) * | 2006-06-26 | 2019-02-18 | Akebia Therapeutics Inc | PROLYL HYDROXYLASE INHIBITORS AND METHODS FOR USE |
| US8269008B2 (en) | 2007-12-03 | 2012-09-18 | Fibrogen, Inc. | Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditions |
| US8952160B2 (en) | 2008-01-11 | 2015-02-10 | Fibrogen, Inc. | Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity |
| US8324405B2 (en) | 2008-02-05 | 2012-12-04 | Fibrogen, Inc. | Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors |
| EP2334682B1 (en) | 2008-08-20 | 2017-10-04 | Fibrogen, Inc. | Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators |
| CN105037323A (zh) | 2008-11-14 | 2015-11-11 | 菲布罗根有限公司 | 作为hif羟化酶抑制剂的苯并噻喃衍生物 |
| HK1203929A1 (en) | 2008-12-03 | 2015-11-06 | 普雷西迪奥制药公司 | Inhibitors of hcv ns5a |
-
2013
- 2013-03-08 JP JP2014561149A patent/JP6129217B2/ja active Active
- 2013-03-08 CA CA2866556A patent/CA2866556C/en active Active
- 2013-03-08 US US14/383,874 patent/US9409892B2/en active Active
- 2013-03-08 NZ NZ700760A patent/NZ700760A/en unknown
- 2013-03-08 EP EP13712970.6A patent/EP2834220B1/en active Active
- 2013-03-08 SG SG11201405574UA patent/SG11201405574UA/en unknown
- 2013-03-08 AU AU2013229922A patent/AU2013229922B2/en active Active
- 2013-03-08 WO PCT/US2013/029912 patent/WO2013134660A1/en not_active Ceased
- 2013-03-08 CN CN201380023358.XA patent/CN104470899B/zh active Active
-
2014
- 2014-09-09 IL IL234544A patent/IL234544A/en active IP Right Grant
-
2017
- 2017-03-13 JP JP2017047346A patent/JP2017101089A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509543A5 (OSRAM) | ||
| CA2512582C (en) | Antibacterial agents | |
| US10968172B2 (en) | USP30 inhibitors | |
| NZ601655A (en) | Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof | |
| JP2007536224A5 (OSRAM) | ||
| JP2015502335A5 (OSRAM) | ||
| HRP20140105T1 (hr) | Novi inhibitori seh i njihova upotreba | |
| CA2536954A1 (en) | C-kit modulators and methods of use | |
| HRP20151260T1 (hr) | Supstituirani nikotinamidi kao modulatori kcnq2/3 | |
| ZA200502755B (en) | 1,3-Diamino-2-hydroxypropane prodrug derivatives. | |
| JP2013509376A5 (OSRAM) | ||
| WO2017195216A4 (en) | Cyclopropyl-amide compounds as dual lsd1/hdac inhibitors | |
| IL259975A (en) | Pyridine compounds are converted to 4-phenyl as unsystematic trg5 agonists | |
| US20070276011A1 (en) | Plasminogen Activator Inhibitor-1 Inhibitor | |
| NZ603198A (en) | Novel hydroxamic acid derivative | |
| SK94196A3 (en) | Metalloproteinase inhibitors, pharmaceutical compositions containing them, manufacturing process thereof and their use | |
| JP2015517981A5 (OSRAM) | ||
| JP2008502700A5 (OSRAM) | ||
| WO2014098098A1 (ja) | 複素環アミド誘導体及びそれを含有する医薬 | |
| US20090306133A1 (en) | New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087 | |
| CA2570942A1 (en) | Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicament | |
| JP2004527503A5 (OSRAM) | ||
| RU2012134093A (ru) | 4-фенокси-никотинамиды или 4-фенокси-пиримидин-5-карбоксамиды | |
| UA90757C2 (ru) | Гербицидная композиция, способ борьбы с нежелательной растительностью и способ защиты посевов от фитотоксичного действия 3-фенилурацилов | |
| CA2645291A1 (en) | Dibenzyl amine derivatives as cetp inhibitors |